Solera Health adds new gut health offering

Solera Health, a digital platform that provides a marketplace for chronic disease management benefits and programs, is expanding its reach into the digestive space. The Phoenix, Arizona-based company has announced that it will offer gastrointestinal-focused digital health products from Oshi Health and Vivante Health.

Oshi provides virtual-first GI care for patients with a variety of conditions. The service includes health coaching, nutritional and mental health support, personalized care plans and lab tracking tools, as well as services to track symptoms and contact care teams, according to the company’s webpage.

Vivante Health’s platform offers 24-hour support from nurses, registered dietitians and health coaches. It also includes a service that monitors a member’s gut chemistry. The platform also provides users with nutrition education, coaching, symptom monitoring and personalized reports.


These new offerings expand Solera’s reach into the GI space. Digestive disorders are common in the US. In fact, 60 million to 70 million people in the US suffer from digestive disorders, according to the National Institute of Diabetes and Digestive and Kidney Diseases.

“Digestive diseases affect nearly one in five Americans and cost more than $140 billion a year in direct and indirect costs to employers and health plans,” said Mary Langowski, CEO of Solera Health, in a statement. “These conditions are often difficult to diagnose and treat, but with our curated network of world-class digital solutions in Oshi and Vivante, we are dramatically simplifying access for member populations by accelerating time to diagnosis and driving better outcomes. More than just Already by building this partner network, we are also helping to drive member enrollment and engagement to maximize cost savings and provide a comprehensive solution.”


Solera Health’s offerings include a number of chronic conditions and lifestyle conditions, such as diabetes, hypertension, weight management, smoking cessation, stress and poor sleep. In 2019, the company raked in $42 million in Series C financing, bringing total proceeds to $72 million.

This is not the first collaboration for Oshi. Earlier this month, the company announced a partnership with Firefly Health to provide digestive care to the members of the former. In October 2021, Oshi scored $23 million in Series A financing.

Vivante Health has also been involved in a number of deals in the past. For example, in 2020 the company signed a deal with consumer health company Welltok (now part of Virgin Pulse) to offer its bowel program to Welltok members. Earlier this month, Vivante Health announced a $16 million Series A financing round led by 7wireVentures.